JOSÉ JAVIER GÓMEZ BARRADO
PROFESOR ASOCIADO (T.P. 6 HORAS LECTIVAS/5 HORAS TUTORÍAS)
Departamento de CIENCIAS BIOMÉDICAS
FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD
- Scopus: 6701842661
- Dialnet: 2146492
- Índice H: 8
Tutorías
PRIMER SEMESTRE | ||||
---|---|---|---|---|
Día | Horario | Despacho | ||
Martes | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD | ||
Jueves | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD |
SEGUNDO SEMESTRE | ||||
---|---|---|---|---|
Día | Horario | Despacho | ||
Martes | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD | ||
Jueves | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD |
PERIODO NO LECTIVO | ||||
---|---|---|---|---|
Día | Horario | Despacho | ||
Martes | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD | ||
Jueves | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD |
PERIODO LECTIVO DE EXÁMENES | ||||
---|---|---|---|---|
Día | Horario | Despacho | ||
Martes | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD | ||
Jueves | 18:00 - 20:30 | A determinar - FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD |
Asignaturas
Consulta toda la información investigadora de JOSÉ JAVIER GÓMEZ BARRADO en el Portal de Investigación.
Publicaciones:
- 2024: Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice
- 2024: Lipoprotein (a) is a predictor of non-achievement of LDL-C goals in patients with chronic heart disease
- 2024: Nutritional intervention in chronic heart failure patients: A randomized controlled clinical trial
- 2024: Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination
- 2023: Clinical evolution of patients with AF and diabetes mellitus in the COVID-19 pandemic. REFADI Registry
- 2023: Eosinophilic myocarditis as presentation of hypereosinophilic syndrome
- 2022: Lipoprotein(a) in a selection of hospitals in Andalusia and Extremadura. Underdiagnosed and underused?
- 2022: Safety and effectiveness of edoxaban in clinical practice after one year of follow-up in Spain. The ETNA-AF-EUROPE registry
- 2021: Clinical characteristicas of patients suffering atrial fibrillation and diabetes mellitus. The attitude of the clinical cardiologist
- 2021: Modification of the forms of self-determined regulation and quality of life after a cardiac rehabilitation programme: Tennis-based vs. bicycle ergometer-based